Home Ahead of print Instructions Contacts
About us Current issue Submit article Advertise  
Editorial board Archives Subscribe Login   
Year : 2021  |  Volume : 27  |  Issue : 1  |  Page : 26-29

Risk of hepatic toxicity and drug response in patients with chronic suppurative otitis media

1 Department of ENT, Jinnah Sindh Medical University, Karachi, Pakistan
2 Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi, Pakistan
3 Dean of Faculty of Pharmacy, Federal Urdu University of Science and Technology, Karachi, Pakistan
4 Department of Pathology, Jinnah Post Medical College, Karachi, Pakistan
5 Department of ENT, Jinnah Post Medical College, Karachi, Pakistan
6 Head of Pharmaceutical Chemistry, School of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan

Correspondence Address:
Dr. Shafaque Mehboob
Assistant Prof, Department of Pharmaceutical Chemistry, Institute of Pharmacy, Jinnah Sindh Medical University, Karachi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/indianjotol.INDIANJOTOL_25_20

Rights and Permissions

Objective: The aim of the current study was to evaluate the risk of hepatic and renal toxicity in patients with chronic suppurative otitis media (CSOM) and the effects of antibiotics (ciprofloxacin and co-amoxicillin) on it. Methods: This is a case–control study conducted on patients and healthy volunteers divided into four groups; G1 (negative control), G2 (positive control), G3 (patients treated with ciprofloxacin), and G4 (patients treated with co-amoxicillin). The study was conducted in Jinnah Postgraduate Medical College in Karachi, Pakistan, from May 2018 to October 2018. Results: There was a significant (P < 0.05) increase in total bilirubin, direct bilirubin, alkaline phosphatase, Serum glutamic pyruvic transaminase (SGPT), and Gamma-glutamyl transferase (GGT) in patients of G2 (positive control) as compared to G1 (negative control). However, the treatment with antibiotics may recover the normal liver enzyme levels except direct bilirubin and SGPT. An insignificant increase in blood glucose levels and urea was found in G2, G3, and G4 with insignificant increased creatinine levels. Conclusion: Hepatic toxicity may be induced in patients with CSOM, particularly if not properly treated. Therefore, precautions with proper follow-up of liver function test should be taken in CSOM.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded35    
    Comments [Add]    

Recommend this journal